PRESS INVITATION

(NGM: SCN)

Could a virus be one of the explanations behind the world-wide epidemic development of obesity? Research indicates that adenovirus 36 (AD36) turns ordinary fat cells into fat-storing cells.

SCN has entered into a global licensing agreement regarding all research around the obesity virus AD36 with the American Professor Richard L. Atkinson. At the same time, SCN is also entering into research collaboration with Karolinska Institutet, in addition to the existing SCN-KI Network of Excellence.

Welcome to a press conference regarding the research around AD36, the development of diagnostic methods, additional indications besides obesity and future treatments.

Date and time: Today, Tuesday, April 8, at 12.00 noon

Place: Centrum för Molekylär Medicin (CMM), Karolinska Universitetssjukhuset, Solna, building L8 (a map can be found on CMM’s website: http://www.cmm.ki.se/omCMM/documents/KartaCMM.ppt)

A lighter lunch will be served.

Program

12.00 Anders Struksnes, COO at SCN, about the agreements

12.10 Dan Edwall, VP R&D at SCN, about AD36 connected to obesity and future indications

12.20 Martin Schalling, Professor at the Center for Molecular Medicine, about the role of Karolinska Institutet in the research

12 .30-13.15 Professor Richard L. Atkinson about the research done around AD36.

The press conference will also be available via webcast on SCN’s website www.scnutrition.com later the same day.

For more information, please contact:

Anders Struksnes, COO SCN, as@scnutrition.com, +47 911 98 942

Dan Edwall, VP R&D, de@scnutrition.com, +46 70 798 80 89

Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Coldizin, Immulina and Ledactin. Core competence and strategic alliances within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth on the international market. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).